questionText: To ask the Secretary of State for Health and Social Care, what assessment the Department has made of the level of suicides and attempted suicides among (a) people prescribed dopamine agonists who have experienced impulse control disorders, augmentation or dopamine agonist withdrawal syndrome and (b) immediate family members or co-habitants affected by the consequences of a relative’s dopamine agonist-induced impulse control disorder.
answerText: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...
heading: Drugs: Side Effects